-
-
Call more information
660-596-2224 -
Practical Pain Management Jan 2023 DEA Update on Buprenorphine Prescribing Waivers Clinicians now face one less hurdle in treating patients with opioid use disorder (OUD). As a part of the Consolidation Appropriations Act of 2023, the federal DATA-waiver, or X-waiver, has been removed, making it easier for clinicians to use buprenorphine (marketed under a variety […]
Read MoreAuthor: Michael Walter Cardiovascular Business When treating patients with prior coronary artery bypass grafting (CABG) surgery and recurrent angina, repeat CABG is associated with a better mortality rate than percutaneous coronary intervention (PCI). PCI, however, is associated with better operative outcomes, meaning clinicians will need to weight the risks and benefits of each treatment option […]
Read MoreAuthor: Riz Hatton Becker’s ASC Review Several healthcare leaders see a bright future for ASCs and expect the market to grow in 2023. Three healthcare leaders connected with Becker’s to answer, “What does 2023 have in store for the ASC industry?” Editor’s note: Responses have been lightly edited for length and clarity. Braden Batkoff, MD. Chief Medical […]
Read MoreAuthors: Paul S. Pagel, M.D., Ph.D. et al Anesthesiology January 2023. To the Editor: We read with interest the recent review of aortic biomechanics and their clinical applications by Gregory et al. The authors should be congratulated for addressing this important but often underappreciated subject. Nevertheless, we are obligated to mention that the authors did not […]
Read MoreAuthors: Alexander J. Gregory, M.D., F.R.C.P.C.; Gary M. Dobson, M.D.C.M., M.Sc., F.R.C.P.C. Anesthesiology January 2023. In Reply: We thank the authors for their thoughtful letter and informative review regarding the effects of anesthesia on the cardiovascular system. This previous work using animal models has been foundational in framing our understanding of arterial physiology and the effects of […]
Read More